Overview Assessment of Efficacy of Vardenafil in Subjects With Erectile Dysfunction and Diabetes, Hypertension or Hyperlipidemia Status: Completed Trial end date: 2004-06-01 Target enrollment: Participant gender: Summary Assessment of efficacy of vardenafil in subjects with erectile dysfunction and diabetes, hypertension or hyperlipidemia Phase: Phase 3 Details Lead Sponsor: BayerTreatments: TadalafilVardenafil Dihydrochloride